<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541434</url>
  </required_header>
  <id_info>
    <org_study_id>14/30-09-2016 CHPatras</org_study_id>
    <nct_id>NCT03541434</nct_id>
  </id_info>
  <brief_title>Bioclinical Profile of Adenotonsillar Hypertrophy in the Pediatric Population</brief_title>
  <official_title>Analysis of Clinical, Pathologic and Molecular Markers of Adenotonsillar Hypertrophic Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Patras</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenotonsillar hypertrophy is the principal cause of obstructive sleep apnea of childhood,
      yet little is known with regard to its pathophysiologic and molecular mechanisms. The present
      trial examines potential bioclinical markers of the disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Tonsils and adenoids comprise the main bulk of Waldeyer's ring, which is commonly
      enlarged in childhood, until the age of 11. Obstructive sleep apnea caused by adenotonsillar
      hypertrophy is a major contributing factor to cardiorespiratory morbidity in the pediatric
      population. It is also responsible for otitis media with effusion, the most frequent cause of
      children's hearing loss. Even so, there is scarce knowledge of its molecular pathogenesis.

      Objective: Identification of clinical/molecular markers of adenotonsillar enlargement and
      investigation of their participation in the process of tissue hypertrophy.

      Methods: A prospective cohort of children with adenotonsillar hypertrophy were recruited
      starting on 02/01/2017 and ending on 12/22/2017. Demographic and clinical data including age,
      gender, sleep apnea severity, tonsillar size, presence of middle ear effusion, family
      history, review of systems as well as tympanometric and complete blood count results were
      recorded. Blood samples and tissue specimens from the therapeutic adenotonsillectomy
      procedure were archived for future analyses. Children with chronic tonsillitis and/or
      adenoiditis, who also underwent excision of tonsils and/or adenoids served as study controls.
      Informed consent was obtained from parents of all study participants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">December 20, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bioclinical profile of adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Clinical, laboratory, and molecular markers of adenotonsillar hypertrophy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical markers of adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Clinical findings from history (sympoms) and physical exam (signs) suggestive of adenotonsillar hypertrophy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory markers of adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Complete blood count (cells/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tympanometric findings of middle ear disease resulting from adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Middle ear pressure (dekaPascals)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wide-Band tympanometric findings of middle ear disease resulting from adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Resonance frequency of the middle ear (Hz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Molecular determinants of adenotonsillar hypertrophy</measure>
    <time_frame>One year post surgical procedure</time_frame>
    <description>Immunohistochemical expression of molecular factors involved in tissue growth (semiquantitative scale)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">134</enrollment>
  <condition>Enlargement of Tonsil or Adenoid</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Children with no history of adenotonsillar hypertrophy, recurrent tonsillitis, or middle ear effusion. They presented to the clinic for examination or a scheduled procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Recurrent tonsillitis</arm_group_label>
    <description>Children with a history of recurret tonsillitis but no adenotonsillar hypertrophy. Diagnosis was based on physical exam and complete blood count. They presented to the clinic for a sceduled tonsillectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Middle ear effusion</arm_group_label>
    <description>Children with chronic middle ear effusion but no adenotonsillar hypertrophy. Diagnosis was based on physical exam and tympanometry. They presented to the clinic for scheduled myringotomy with or without adenoidectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adenotonsillar hypertrophy</arm_group_label>
    <description>Children with tonsillar and/or adenoidal hypertrophy. Diagnosis was based on physical exam and partly on x-ray of nasopharynx or nasopharyngoscopy. They presented to the clinic for scheduled tonsillectomy and/or adenoidectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Complete Blood Count</intervention_name>
    <description>White blood cell subgroups count</description>
    <arm_group_label>Adenotonsillar hypertrophy</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Middle ear effusion</arm_group_label>
    <arm_group_label>Recurrent tonsillitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tympanometry</intervention_name>
    <description>Conventional and multifrequency tympanometry, documenting middle ear admittance and absorbance</description>
    <arm_group_label>Adenotonsillar hypertrophy</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Middle ear effusion</arm_group_label>
    <arm_group_label>Recurrent tonsillitis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tonsillectomy and/or adenoidectomy</intervention_name>
    <description>Excision of palatine and/or pharyngeal tonsils.</description>
    <arm_group_label>Adenotonsillar hypertrophy</arm_group_label>
    <arm_group_label>Middle ear effusion</arm_group_label>
    <arm_group_label>Recurrent tonsillitis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood was centrifuged and cells were separated from supernatants. Both were stored at -80
      degrees.

      Palatine and pharyngeal tonsillar tissue specimens were divided in half. One part was fixated
      in 4% formaldehyde for 24 hours and then stored in saline at 4 degrees. The other part was
      stored immediately at -80 degrees.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All children presenting to the clinics of a Pediatric hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Available history and physical exam findings

          -  Available complete blood count and tympanometry at admission

        Exclusion Criteria:

          -  Previous tonsillectomy and/or adenoidectomy.

          -  Previous ear surgery.

          -  Acute infection during the past month.

          -  Active severe systemic disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgios T Stathopoulos</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor of Physiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children Hospital of Patras &quot;Karamandaneio&quot;</name>
      <address>
        <city>Patras</city>
        <state>Achaia</state>
        <zip>26331</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Patras University Hospital</name>
      <address>
        <city>Rio</city>
        <state>Achaia</state>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <results_reference>
    <citation>Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Ward SD, Sheldon SH, Shiffman RN, Lehmann C, Spruyt K; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):e714-55. doi: 10.1542/peds.2012-1672. Epub 2012 Aug 27. Review.</citation>
    <PMID>22926176</PMID>
  </results_reference>
  <results_reference>
    <citation>Liou HC. Regulation of the immune system by NF-kappaB and IkappaB. J Biochem Mol Biol. 2002 Nov 30;35(6):537-46. Review.</citation>
    <PMID>12470586</PMID>
  </results_reference>
  <results_reference>
    <citation>Heneghan AF, Pierre JF, Kudsk KA. JAK-STAT and intestinal mucosal immunology. JAKSTAT. 2013 Oct 1;2(4):e25530. doi: 10.4161/jkst.25530. Epub 2013 Jun 26. Review.</citation>
    <PMID>24416649</PMID>
  </results_reference>
  <results_reference>
    <citation>Min HJ, Kim SJ, Kim TH, Chung HJ, Yoon JH, Kim CH. Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis. Laryngoscope. 2015 Jul;125(7):E225-30. doi: 10.1002/lary.25172. Epub 2015 Jan 30.</citation>
    <PMID>25639490</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 9, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Patras</investigator_affiliation>
    <investigator_full_name>Georgios Stathopoulos</investigator_full_name>
    <investigator_title>Associate Professor of Physiology</investigator_title>
  </responsible_party>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>tonsillitis</keyword>
  <keyword>middle ear effusion</keyword>
  <keyword>pathophysiology</keyword>
  <keyword>score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

